CELEX: 62016CA0642
Language: en
Date: 2018-05-17 00:00:00
Title: Case C-642/16: Judgment of the Court (Fifth Chamber) of 17 May 2018 (request for a preliminary ruling from the Bundesgerichtshof, Germany) — Junek Europ-Vertrieb GmbH v Lohmann & Rauscher International GmbH & Co. KG (Reference for a preliminary ruling — Intellectual property — Trade-mark law — Regulation (EC) No 207/2009 — Article 13 — Exhaustion of the rights conferred by a trade mark — Parallel imports — Repackaging of the product bearing the mark — New labelling — Conditions applicable to medical devices)

201806220251970762018/C 240/066422016CJC24020180709EN01ENINFO_JUDICIAL201805175511Case C-642/16: Judgment of the Court (Fifth Chamber) of 17 May 2018 (request for a preliminary ruling from the Bundesgerichtshof, Germany) — Junek Europ-Vertrieb GmbH v Lohmann & Rauscher International GmbH & Co. KG (Reference for a preliminary ruling — Intellectual property — Trade-mark law — Regulation (EC) No 207/2009 — Article 13 — Exhaustion of the rights conferred by a trade mark — Parallel imports — Repackaging of the product bearing the mark — New labelling — Conditions applicable to medical devices)
 ---documentbreak--- C2402018EN510120180517EN00065151Judgment of the Court (Fifth Chamber) of 17 May 2018 (request for a preliminary ruling from the Bundesgerichtshof, Germany) — Junek Europ-Vertrieb GmbH v Lohmann & Rauscher International GmbH & Co. KG
   (Case C-642/16) (
         1
      )
   ‛(Reference for a preliminary ruling — Intellectual property — Trade-mark law — Regulation (EC) No 207/2009 — Article 13 — Exhaustion of the rights conferred by a trade mark — Parallel imports — Repackaging of the product bearing the mark — New labelling — Conditions applicable to medical devices)’2018/C 240/06Language of the case: German
      Referring court
   
   Bundesgerichtshof
   
      Parties to the main proceedings
   
   
      Applicant: Junek Europ-Vertrieb GmbH
   
      Defendant: Lohmann & Rauscher International GmbH & Co. KG
   
      Operative part of the judgment
   
   Article 13(2) of Council Regulation (EC) No 207/2009 of 26 February 2009 on the European Union trade mark must be interpreted as meaning that the proprietor of a mark cannot oppose the further commercialisation, by a parallel importer, of a medical device in its original internal and external packaging where an additional label, such as that at issue in the case in the main proceedings, has been added by the importer, which, by its content, function, size, presentation and placement, does not give rise to a risk to the guarantee of origin of the medical device bearing the mark.
   (
         1
      )	OJ C 104, 3.4.2017.